Labcorp Holdings Inc (LH) Growth Rates Comparisons to Medical Laboratories Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Labcorp Holdings Inc   (NYSE: LH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Labcorp Holdings Inc Growth Comparisons

Select each growth Category to receive further Information





LH Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 6.92 % 9.3 % 10.18 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) 2.11 % -4.17 % -2.46 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 6.02 % 9.49 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 1.72 % 2.32 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 3.84 % 13.12 % 8.67 % 13.63 %


LH's Growth Comparisons in III. Quarter 2026




Comparing 6.92% year on year top-line growth in the third quarter 2026, Labcorp Holdings Inc grew on the lower pace than the 9.3% growth in the Medical Laboratories industry and 10.18% Revenue improvement in the Healthcare sector. Slow third quarter sales, in the Medical Laboratories industry and Healthcare sector, were portrayed in Labcorp Holdings Inc results which underperformed overall market.

Comparing the company's Revenue to the second quarter results, sales were higher by 2.11% . On the yearly basis, average annual sales growth for Labcorp Holdings Inc is 3.84%, while S & P 500's including only Businesses with the third quarter 2026 earnings, average annual sales growth is 13.63% over the past five years.

LH Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
UNITED STATES
209.2 %
52.73 %
Intersegment Eliminations
-
51.38 %
Total
6.92 %
2.11 %


Growth Rates of LH's Income in the third quarter 2026


LH Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 1.39 % 51.98 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) -10.96 % 0.29 % -12.21 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) 12.63 % 91.83 % 30.98 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) 0.37 % 10.42 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change 0.81 % 6.34 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 0.5 % 29.87 % -38.86 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) -12.14 % 7.6 % -63.27 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 17.33 % 3.68 % 9.88 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 0.13 % 14.82 % -4.67 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 1.25 % 5.06 % 8.91 % -28.64 %

LH Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 0.5 % 10.27 % -39.2 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) -12.14 % 6.76 % 11.78 % 27.07 %
Y / Y Net Income Change (Q3 TTM) 17.33 % 188.03 % 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) 0.13 % 13.57 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth 1.25 % 5.34 % 9.09 % 23.95 %

LH's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 3.18 % 21.37 % -38.86 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) -11.48 % 1.53 % -63.27 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 19.63 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 0.82 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 7.82 % -8.01 % 8.91 % -28.64 %



LH EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 3.21 % 3.06 % -39.2 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) -11.54 % 0.74 % 11.78 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 0.83 % - 10.63 % 4.93 %
EPS Net 5 Year Avg. Change 7.84 % 5.34 % 9.09 % 23.95 %



Softening Labcorp Holdings Inc 's 3.21% year on year EPS improvement, in the third quarter to $3.22 , outgrows the 3.06% growth in the Medical Laboratories industry, and -39.2% cut in the Healthcare sector.

Sequentially company's EPS fell by -11.54% from the second quarter results. . Looking into annual growth, income per share grew by 7.84% on average in last five years, while S & P 500's including only Businesses with the third quarter 2026 reports, average yearly income per share growth is 23.95%.

LH Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 41.6 % -2.61 % 44.26 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) 26.54 % -75.4 % -42.65 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) -7.89 % 28.25 % 19.33 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) 10.1 % 0.7 % 5.88 % 15.75 %
Free Cash Flow 5 Year Avg. Change 2.9 % 10.39 % 0.41 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - 16.28 % - 152.64 %
Net Cash Flow 5 Year Avg. Change - -9.51 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 56.14 % 45.83 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) 26.6 % 9.03 % -19.32 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) 28.48 % 23.88 % 9.34 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) 12.4 % 11.14 % 0.99 % 23.05 %
Capital Expenditures 5 Year Avg. Change 1.66 % 8.7 % 8.61 % 14.19 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.